When will the coronavirus vaccines for children and adolescents arrive?

Laboratories are playing the race to have perfect antidotes against the coronavirus for minors. The United States, producer of several of the drugs that generate immunity against SARS-CoV-2, has already authorized the use of Pfizer-BioNTech in minors between 12 and 15 years old. As, Modern has been shown to be effective in adolescents between 12 and 17 years old and had no new or major safety concerns in a clinical trial, which could set the stage for a second inoculation school-aged children who would be allowed to July.

The test of Modern (approved for adults over 18) tested the formula in 3732 adolescents aged 12 to 17, two-thirds of whom received the vaccine and one-third a placebo. The main objective was to produce a immune response comparable to that seen in the Company’s large phase 3 adult trial, which had a 94.1% efficiency in the prevention of COVID-19. It took US regulators about a month to review a similar study from Pfizer / BioNtech, which was approved for the past 12 to 15 years. May 10. If Moderna receives the same treatment, his authorization would arrive in early July.

// What measures work and what not to prevent coronavirus infections

What about vaccines applied in Argentina

The outlook with the AstraZeneca, the Sputnik V and the Sinopharm for minors are not very encouraging so far. In addition, the vaccination plan in the country is advancing at a slow pace among adults.

Russian vaccine developers Sputnik V they showed their anger in front of the delay of approval for the application of its antidote in minors. Alexander Ginzburg, said the director of the Gamaleya Center, in dialogue with the Russian agency Ría Novosti: “We are starting to fall behind and will do so irrevocably soon. I mean, our children will not be protected, despite the fact that we were the first to register the vaccine (for minors) ”.

// Certain coronavirus vaccines could be the key to creating a universal cancer formula

Ginzburg insisted in the Russian media on the need to “get permission use the Sputnik V vaccine In children. ”In addition, he said that“ adolescents over the age of 14 have no physiological contraindications ”to his vaccine. However, delays in its approval will inevitably have an impact on Argentina.

Regarding the Chinese vaccine Sinopharm -also administered in the country-, there is no news on the vaccination of minors. Something similar happens with the vaccine Oxford-AstraZeneca, since, in England, he was suspended his trial (it was in phase 2) which was carried out on 300 volunteers aged 6 to 17 years.

// What is the “black fungus” that has already recorded a case in Uruguay: it is linked to COVID-19 and diabetes

After the global controversy generated by the thrombosis In some adults who had been inoculated with AstraZeneca – now banned in several countries – research on the efficiency of the antidote for boys and adolescents has gone nowhere.

What he knows so far is that the stay of trials will last until the UK Medicines Regulatory Agency (MHRA) provides further Side effects of this vaccine. “Although the security in the pediatric clinical trial, Oxford decided to await further information from the MHRA in its investigation into Rare cases thrombosis before giving more vaccines, ”they said. With Sputnik on hold and little news from other drug companies, it looks like vaccines for minors they are far from being applied soon in Argentina.